Sökning: onr:"swepub:oai:gup.ub.gu.se/205342" > Assessment of the b...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03998naa a2200517 4500 | |
001 | oai:gup.ub.gu.se/205342 | |
003 | SwePub | |
008 | 240528s2014 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:bd341b2a-9021-40fc-afd0-7edcb89600c4 | |
024 | 7 | a https://gup.ub.gu.se/publication/2053422 URI |
024 | 7 | a https://doi.org/10.1016/j.urolonc.2014.08.0062 DOI |
024 | 7 | a https://lup.lub.lu.se/record/46911282 URI |
040 | a (SwePub)gud (SwePub)lu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Armstrong, Andrew J4 aut |
245 | 1 0 | a Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC). |
264 | 1 | b Elsevier BV,c 2014 |
520 | a Drug development and clinical decision making for patients with metastatic prostate cancer (PC) have been hindered by a lack of quantitative methods of assessing changes in bony disease burden that are associated with overall survival (OS). Bone scan index (BSI), a quantitative imaging biomarker of bone tumor burden, is prognostic in men with metastatic PC. We evaluated an automated method for BSI calculation for the association between BSI over time with clinical outcomes in a randomized double-blind trial of tasquinimod (TASQ) in men with metastatic castration-resistant PC (mCRPC). | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
700 | 1 | a Kaboteh, Rezau Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xkabre |
700 | 1 | a Carducci, Michael A4 aut |
700 | 1 | a Damber, Jan-Erik,d 1949u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology4 aut0 (Swepub:gu)xdamja |
700 | 1 | a Stadler, Walter M4 aut |
700 | 1 | a Hansen, Mats4 aut |
700 | 1 | a Edenbrandt, Lars,d 1957u Lund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Nuklearmedicin, Malmö,Forskargrupper vid Lunds universitet,Nuclear medicine, Malmö,Lund University Research Groups4 aut0 (Swepub:lu)klfy-led |
700 | 1 | a Forsberg, Göran4 aut |
700 | 1 | a Nordle, Orjan4 aut |
700 | 1 | a Pili, Roberto4 aut |
700 | 1 | a Morris, Michael J4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Urologic oncologyd : Elsevier BVg 32:8, s. 1308-1316q 32:8<1308-1316x 1873-2496 |
773 | 0 | t Urologic Oncology: Seminars and Original Investigationsd : Elsevier BVg 32:8, s. 1308-1316q 32:8<1308-1316x 1078-1439 |
856 | 4 | u https://europepmc.org/articles/pmc6341998?pdf=render |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/25240761?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1016/j.urolonc.2014.08.006y FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/205342 |
856 | 4 8 | u https://doi.org/10.1016/j.urolonc.2014.08.006 |
856 | 4 8 | u https://lup.lub.lu.se/record/4691128 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.